Published in Lupus on September 29, 2011
Platelets: active players in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol (2012) 1.17
C4d as a Diagnostic Tool in Proliferative GN. J Am Soc Nephrol (2015) 1.03
Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther Adv Musculoskelet Dis (2013) 0.88
Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways. Int J Clin Exp Pathol (2013) 0.85
Biomarkers and updates on pediatrics lupus nephritis. Rheum Dis Clin North Am (2013) 0.80
Biomarkers for childhood-onset systemic lupus erythematosus. Curr Rheumatol Rep (2015) 0.79
Is cellular C4d a good biomarker for SLE nephritis? Lupus (2012) 0.78
Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus. Lupus Sci Med (2016) 0.75
New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus. Curr Rheumatol Rep (2017) 0.75
The role of the phagocyte in host-parasite interactions. 13. The direct quantitative estimation of H2O2 in phagocytizing cells. Biochim Biophys Acta (1968) 5.12
A unique structure at the carboxyl terminus of the largest subunit of eukaryotic RNA polymerase II. Proc Natl Acad Sci U S A (1985) 3.98
Mechanism of suppression of cell-mediated immunity by measles virus. Science (1996) 3.55
Medical student education in managed care settings: beyond HMOs. JAMA (1996) 2.84
Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology (2004) 2.81
A report of 104 transfusion errors in New York State. Transfusion (1992) 2.80
Dynamic markers of altered gait rhythm in amyotrophic lateral sclerosis. J Appl Physiol (1985) (2000) 2.76
Cloning and sequence analysis of the mouse genomic locus encoding the largest subunit of RNA polymerase II. J Biol Chem (1987) 2.76
C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol (1997) 2.69
The National Practitioner Data Bank. Report from the first year. JAMA (1992) 2.51
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) (1985) 2.01
Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc Natl Acad Sci U S A (1996) 1.73
The effects of medical school curricula, faculty role models, and biomedical research support on choice of generalist physician careers: a review and quality assessment of the literature. Acad Med (1995) 1.72
Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science (1991) 1.63
The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol (2001) 1.59
Inhibitors of nucleoside transport. A structure-activity study using human erythrocytes. J Med Chem (1975) 1.52
Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med (1996) 1.52
[Effects of Radix angelicae sinensis on systemic and portal hemodynamics in cirrhotics with portal hypertension]. Zhonghua Nei Ke Za Zhi (1996) 1.49
A new financial framework: lessons from Canada. Health Aff (Millwood) (1989) 1.45
Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J Exp Med (1993) 1.44
Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I. J Clin Microbiol (1992) 1.42
A systematic analysis of how medical school characteristics relate to graduates' choices of primary care specialties. Acad Med (1997) 1.41
Factor II, VII, IX and X concentrations in patients receiving long term warfarin. J Clin Pathol (1987) 1.41
Runners adjust leg stiffness for their first step on a new running surface. J Biomech (1999) 1.40
Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2. J Exp Med (1989) 1.35
Innovative approaches to educating medical students for practice in a changing health care environment: the National UME-21 Project. Acad Med (2001) 1.29
Spectral integration in primary auditory cortex: laminar processing of afferent input, in vivo and in vitro. Neuroscience (2005) 1.29
Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum (1982) 1.27
Myocardial blood-flow response during mental stress in patients with coronary artery disease. Lancet (2000) 1.25
Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells. Br J Cancer (2003) 1.25
Lipid accumulation and acid lipase deficiency in fibroblasts from a family with Wolman's disease, and their apparent correction in vitro. J Lab Clin Med (1972) 1.22
Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor. J Exp Med (1991) 1.18
Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex. J Exp Med (1991) 1.17
Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure. Kidney Int (2001) 1.16
Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer. J Urol (2000) 1.15
Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2. J Exp Med (1991) 1.15
Inhibitors of nucleoside and nucleotide metabolism. Cancer Chemother Rep 2 (1972) 1.12
Binding of the nucleoside transport inhibitor 4-nitrobenzylthioinosine to erythrocyte membranes. Can J Biochem (1973) 1.11
Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry (1999) 1.11
Bilateral ischemic optic neuropathy and retinal vascular occlusions associated with lymphoma and sepsis. Clinicopathologic correlation. Ophthalmology (1990) 1.11
Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE). Ann Hum Genet (2006) 1.10
Growth of NS0 cells in protein-free, chemically defined medium. Biotechnol Prog (2000) 1.09
Fungal keratitis from nylon line lawn trimmers. Am J Ophthalmol (1992) 1.08
Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). Mol Immunol (1999) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Prognostic implications of p53 and bcl-2 expression in 108 women with stage two breast cancer. Ir J Med Sci (2001) 1.07
Mapping personal, familial, and professional values in long-term care decisions. Gerontologist (1993) 1.06
Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells. Oncogene (2006) 1.06
Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure. Nephrol Dial Transplant (1999) 1.06
Pseudohypoparathyroidism: its phenotypic variability and associated disorders in a large family. Q J Med (1991) 1.06
Interaction of iC3b with recombinant isotypic and chimeric forms of CR2. J Immunol (1991) 1.03
Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int (1999) 1.03
Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR. Oncogene (2012) 1.02
Lipid studies in Wolman's disease. Pediatrics (1970) 1.02
Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int (1996) 1.01
Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus. Curr Rheumatol Rep (2001) 0.99
Training needs for providing case management for the long-term care client: lessons from the National Channeling Demonstration. Gerontologist (1988) 0.98
Muscle mechanics by velocity vector imaging-questioning the questions themselves! Indian Heart J (2012) 0.97
Ovarian steroidogenesis and development of fetuses following ochratoxin A treatment in pregnant rats. Endokrinologie (1981) 0.97
Synthesis of 6'-cyano-6'-deoxyhomoadenosine-6'-phosphonic acid and its phosphoryl and pyrophosphoryl anhydrides and studies of their interactions with adenine nucleotide utilizing enzymes. J Am Chem Soc (1973) 0.96
Application of UMLS indexing systems to a WWW-based tool for indexing of digital images. Proc AMIA Annu Fall Symp (1997) 0.96
Fluorinated carbohydrates as potential plasma membrane modifiers. Synthesis of 4- and 6-fluoro derivatives of 2-acetamido-2-deoxy-D-hexopyranoses. Carbohydr Res (1990) 0.96
Enhancing early bladder cancer detection with fluorescence-guided endoscopic optical coherence tomography. Opt Lett (2003) 0.96
Reliability of posturographic measurements in the assessment of impaired sensorimotor function in chronic low back pain. J Electromyogr Kinesiol (2007) 0.96
Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats. Ren Fail (2000) 0.96
Biochemical characteristics, metabolism, and antitumor activity of several acetylated hexosamines. J Supramol Struct (1977) 0.95
Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21). J Virol (1993) 0.92
Relationships of HLA-DR and MT antigens to autoantibody expression in systemic lupus erythematosus. Arthritis Rheum (1983) 0.92
Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure. Am J Physiol Renal Physiol (2004) 0.91
ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure. Am J Physiol Renal Physiol (2004) 0.91
Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. Blood (1994) 0.90
Synthesis and biological activity of some 1-N-substituted 2-acetamido-2-deoxy-beta-D-glycopyranosylamine derivatives and related analogs. Carbohydr Res (1980) 0.89
Down-regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int (1997) 0.89
Acute lymphoblastic leukaemia in adults in the northern region of England--a study of 75 cases. Q J Med (1985) 0.89
Protamine sulfate-induced cystitis: a model of selective cytodestruction of the urothelium. Urology (2001) 0.88
Reversible appearance of a specific chromosome which suppresses malignancy. Nature (1974) 0.88
Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure. Am J Physiol (1997) 0.88
Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance. Immunopharmacology (1999) 0.87
Selective thermal effects with pulsed irradiation from lasers: from organ to organelle. J Invest Dermatol (1983) 0.86
Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21). Curr Top Microbiol Immunol (1990) 0.86
Brown's superior oblique tendon syndrome after Baerveldt glaucoma implant. Arch Ophthalmol (1992) 0.86
Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells. Oncogene (2006) 0.86
Acupuncture for systemic lupus erythematosus: a pilot RCT feasibility and safety study. Lupus (2008) 0.86
The BBZ/Wor rat: clinical characteristics of the diabetic syndrome. Diabetologia (1993) 0.85
Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome. Am J Physiol Renal Physiol (2001) 0.85
Can the grey mould disease of the grape-vine be controlled by yeast? FEMS Microbiol Lett (2000) 0.85
Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions. J Pharmacol Exp Ther (2000) 0.85
To compare and contrast the various evaluation scoring systems after anterior cruciate ligament reconstruction. Arch Orthop Trauma Surg (1997) 0.84
Refined linkage map of chromosome 5 in the region of the spinal muscular atrophy gene. Genomics (1993) 0.84
Exploration of Zn resonance levels and thermoelectric properties in I-doped PbTe with ZnTe nanostructures. ACS Appl Mater Interfaces (2014) 0.84
Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection. Am J Kidney Dis (1997) 0.84
The diagnostic value of a multivariate logistic regression analysis model with transvaginal power Doppler ultrasonography for the prediction of ectopic pregnancy. J Int Med Res (2012) 0.83
Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells. J Virol (1994) 0.83
Hematological changes produced in mice by ochratoxin A. Toxicology (1979) 0.83
New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus. Lupus (2004) 0.83
Role of chromatin disruption and histone acetylation in thyroid hormone receptor action: implications in the regulation of HIV-1 LTR. Histol Histopathol (2003) 0.83
Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites. J Biol Chem (1981) 0.82
Apoptosis of skeletal muscle cells and the pathogenesis of myositis: a perspective. Curr Rheumatol Rep (2001) 0.82
Lead-induced hypertension. III. Increased hydroxyl radical production. Am J Hypertens (2001) 0.82